EXOZYMES INC.

EDGAR

Market value is not computed: this company has more than one listed security, and its filing does not count each class separately.

13 filing records in this dataset, filed from 2024-02-09 to 2026-11-13. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-17.

Open-market purchases (code P)
5 transactions, 855 shares
Sum of shares × price per share: 6,405.17
Open-market sales (code S)
3 transactions, 5,229 shares
Sum of shares × price per share: 34,850.7984

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-10-12 Perriman Damien Alan S 3,729 5.2096
  • 2026-10-09 Perriman Damien Alan M 3,922 —
  • 2026-10-09 Perriman Damien Alan M 3,922 0.00
  • 2026-10-01 Bowie James Ulrich A 10,000 0.00
  • 2026-10-01 MARLETT CHRISTOPHER A A 10,000 0.00

See all insider transactions

Latest quarter

Revenue

-700

2023 Q4 ·

Exact inputs and evidence

Operating margin

140,721%

2023 Q4 · %

Exact inputs and evidence
  • Operating Income: -1796222 USD Source
  • Operating Income: -811175 USD Source
  • Revenue: 70069 USD Source
  • Revenue: 70769 USD Source

Operating cash flow

-783 thousand

2023 Q4 ·

Exact inputs and evidence
  • Operating Cash Flow: -1180870 USD Source
  • Operating Cash Flow: -397590 USD Source

Free cash flow

-893 thousand USD

2023 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -1180870 USD Source
  • Operating Cash Flow: -397590 USD Source
  • Capital Expenditure: 288712 USD Source
  • Capital Expenditure: 178969 USD Source
Cash and cash equivalents
3.26 million USD Source
Exact value

3258901 USD

Long-term debt including current maturities
Not available
Shares outstanding
9.3 million shares Source
Exact value

9304701 shares

Reported share-count change

10.94% · 917 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 8387250 shares · 2025-09-30· Source
  • 9304701 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-10.1 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -9158734 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -6503698 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -2370247 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -2878614 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -2238528 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-7.36 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -6502040 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -4528240 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -1524441 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -3164719 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -1524441 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -5386342 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -3164719 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-13.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2023-12-31
  • Operating income: 3 of 11 periods available· newest 2025-12-31
  • Net income: 3 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2025-12-31
  • Total assets: 3 of 11 periods available· newest 2025-12-31
  • Total liabilities: 3 of 11 periods available· newest 2025-12-31
  • Current assets: 3 of 11 periods available· newest 2025-12-31
  • Current liabilities: 3 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 3.3 million

    Prior period

    −USD 5.86 million

    –

    Current period

    −USD 9.16 million

    –

    Exact inputs and evidence

    -9158734 − -5861335 = -3297399 USD

    -5861335 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -9158734 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 2 million

    Prior period

    −USD 8.51 million

    –

    Current period

    −USD 6.5 million

    –

    Exact inputs and evidence

    -6502040 − -8505650 = 2003610 USD

    -8505650 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -6502040 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -57.1%

    Prior period

    USD 396,451

    –

    Current period

    USD 169,917

    –

    Exact inputs and evidence

    169917 − 396451 = -226534 USD

    396451 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    169917 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

  • Revenue USD 70,069 100% of revenue
  • Operating costs Derived USD 1.87 million 2,664% of revenue
  • Operating income −USD 1.8 million −2,564% of revenue
  • Tax, interest and other Derived USD 242,167 346% of revenue
  • Net income −USD 2.04 million −2,909% of revenue

Cash

  • Operating cash flow −USD 1.18 million −1,685% of revenue
  • Capital expenditure USD 288,712 412% of revenue
  • Free cash flow Derived −USD 1.47 million −2,097% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Operating loss: operating costs were 2,664% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-3170069 1866291 Derived -1796222 242167 Derived -2038389 -1469582 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 70.1K 2023
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.75.7K56.8K37.8K18.9K0.02023
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Revenue70069

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2,563.5% 2023
Net margin -2,909.1% 2023
Free cash flow margin -2,097.3% 2023
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.233%-611%-1,455%-2,298%-3,142%2023
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating margin-2,563.5%
2023Net margin-2,909.1%
2023Free cash flow margin-2,097.3%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.2M 2023
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.94.5K-248.0K-590.4K-932.9K-1.3M2023
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Operating cash flow-1180870

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.5M 2023
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.117.6K-308.6K-734.8K-1.2M-1.6M2023
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Free cash flow-1469582

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

110.8% 2023
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.120%90%60%30%0%2023
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023Liabilities / assets110.8%

Current assets to current liabilities

Current assets divided by current liabilities.

0.5× 2023
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.54×0.41×0.27×0.14×0.00×2023
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023Current assets / current liabilities0.5×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
−USD 2.04 million
Exact value

Exact value: -2038389 USD

2023-01-01 – 2023-12-31: -2038389 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.18 million
Exact value

Exact value: -1180870 USD

2023-01-01 – 2023-12-31: -1180870 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 288,712
Exact value

Exact value: 288712 USD

2023-01-01 – 2023-12-31: 288712 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.47 million
Calculation and evidence

-1180870 − 288712 USD

Exact free cash flow: -1469582 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 5.86 million
Exact value

Exact value: -5861335 USD

2024-01-01 – 2024-12-31: -5861335 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.51 million
Exact value

Exact value: -8505650 USD

2024-01-01 – 2024-12-31: -8505650 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 396,451
Exact value

Exact value: 396451 USD

2024-01-01 – 2024-12-31: 396451 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.9 million
Calculation and evidence

-8505650 − 396451 USD

Exact free cash flow: -8902101 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 9.16 million
Exact value

Exact value: -9158734 USD

2025-01-01 – 2025-12-31: -9158734 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 6.5 million
Exact value

Exact value: -6502040 USD

2025-01-01 – 2025-12-31: -6502040 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 169,917
Exact value

Exact value: 169917 USD

2025-01-01 – 2025-12-31: 169917 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 6.67 million
Calculation and evidence

-6502040 − 169917 USD

Exact free cash flow: -6671957 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

13 filings · 561 latest values · 561 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0002010788, 2010788, EXOZ, IZTC, edgar:2010788

Also known as EXOZYMES INC., INVIZYNE TECHNOLOGIES INC., Invizyne Technologies Inc